Ranbaxy starts phase III study of anti-malaria drug
Ranbaxy starts phase III study of anti-malaria drug

Ranbaxy Laboratories announced that its new anti-malarial combination drug is now undergoing final stage of development. In its press-release, the company said that the drug is targeted at patients in developing countries with the aim of significantly improving upon the conventional options available for the treatment of P falciparum malaria.

The time is ripe
The time is ripe

[This article was published in the September 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

Pilot projects such as, �Gramjyoti� (Light of the Village) in India, and �Alokito Bangladesh� (Enlightened Bangladesh) led by Ericsson, have remained pilots for long.

Rural areas reap benefits of telemedicine
Rural areas reap benefits of telemedicine

Quicker access to cardiologists, neurologists or radiologists even in remote places in Karnataka is now a possibility, thanks to advances in telecommunication. Cardiac emergencies like thrombosis are now being attended to by trained doctors at the Chamarajanagar district hospital and at 19 public health centres (PHCs) under the Karuna Trust.

whatsapp--v1 JOIN US
whatsapp--v1